Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide for Lymphorrhea Prevention in Breast Cancer
NCT00630695Phase 3Completed
- Sponsor
- CHU de Limoges
- Start
- Mar 2008
- Primary completion
- Jun 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lanreotide in lymphocele, sponsored by CHU de Limoges. Started Mar 2008; status: completed.
02
Drugs
lanreotide
03
Conditions
lymphocele
Beyond the preview
Go deeper on NCT00630695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630695.